Primary dysmenorrhea from today’s perspective

Gevorgyan A.P.

Department of Reproductive Medicine and Surgery FPDO Moscow State University of Medicine and Dentistry, Russia, Moscow, Russia, 127473

Sibirskaia E.V.

Kafedra reproduktivnoĭ meditsiny i khirurgii fakul'teta poslediplomnogo obrazovaniia Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta;
Izmaĭlovskaia detskaia klinicheskaia bol'nitsa, Moskva

Primary dysmenorrhea from today’s perspective

Authors:

Gevorgyan A.P., Sibirskaia E.V.

More about the authors

Journal: Russian Journal of Human Reproduction. 2018;24(6): 32‑38

DOI: 10.17116/repro20182406132

Downloaded: 29

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Gevorgyan AP, Sibirskaia EV. Primary dysmenorrhea from today’s perspective. Russian Journal of Human Reproduction. 2018;24(6):32‑38. (In Russ.)
https://doi.org/10.17116/repro20182406132

Подписка 2025-2 (Russian Journal of Human Reproduction)

Close metadata

Recommended articles:

Immunohistochemical features and pathogenesis of hyperextensible eyelids. Plastic Surgery and Aesthetic Medicine. 2024;(4):25-33

ABSTRACT Objective — to increase the effectiveness of early diagnosis and to develop a differentiated approach to the treatment of adolescent girls with primary dysmenorrhea (PD). Material and methods. The study was conducted on 100 adolescent girls aged 15 to 17 years, diagnosed with primary dysmenorrhea, who were initially divided into study and control groups depending on the presence or absence of undifferentiated dysplasia of connective tissue (UDCT). Then, to compare the two proposed treatment regimens, each group was divided into 2 subgroups. Basic therapy included drug NSAIDs (Meloxicam 15 mg) and vitamin-mineral complex with a content of Calcium 1000 mg and vitamin D3 800 IU. The second scheme — the basic treatment was added to the drug L-carnitine 800 mg, affecting collagen formation. Self-assessment of menstrual pain was performed using McGill’s pain questionnaire. The levels of free hydroxyproline, MMP-2 and MMP-9, tumor necrosis factor α and serum magnesium were determined. Results. In adolescent girls with UDCT, the level of free blood hydroxyproline was almost 2 times higher than in patients with PD without UDCT (276.78±117.1 ng/ml and 142.64±90.4 groups, p<0.05). In both groups, no cases of magnesium deficiency in the blood were detected. In the analysis of biochemical parameters in serum after treatment, in all groups all blood parameters significantly improved-free hydroxyproline decreased 3 times, MMP-2 — 2.5 times, TNF-α —1.5 times, and MMP-9 increased 5 times (p<0.05). Conclusions. The effectiveness of the proposed treatment of primary dysmenorrhea — the use of NSAIDs in combination with vitamin and mineral complex, including calcium and vitamin D, is confirmed not only by clinical data, but also by biochemical studies (reduction of free hydroxyproline 2.5 times, MMP 2—3 times, TNF-α — 1.5 times and increase of MMP-9 in 4 times (p<0.05).Thus, the proposed therapy with NSAIDs and vitamin and mineral complex, including calcium and vitamin D, it is advisable to appoint patients with primary dysmenorrhea, with signs of PDST, to improve the quality of life in adolescent girls.

Keywords:

primary dysmenorrhea

matrix metalloproteinases

free blood hydroxyproline

undifferentiated connective tissue dysplasia

Authors:

Gevorgyan A.P.

Department of Reproductive Medicine and Surgery FPDO Moscow State University of Medicine and Dentistry, Russia, Moscow, Russia, 127473

Sibirskaia E.V.

List of references:

Sibirskaya EV, Adamyan LV, Koltunov IE, Korotkova SA, Polyakova EI, Gevorgyan AP, Pakhomova PI. Analysis of gynecological morbidity in girls and adolescents. Problemy reproduktsii. 2017;23(6):60-65. (In Russ.) https://doi.org/10.17116/repro201723660-65
Banikarim C, Middleman AB. Primary dysmenorrhea in adolescents. UpToDate, version 13.3, 2005. Available at www.utdol.com.
French L. Dysmenorrhea in adolescents: diagnosis and treatment. Paediatric Drugs. 2008;10(1):1-7. https://doi.org/10.2165/00148581-200810010-00001
Kazama M, Maruyama K, Nakamura K. Prevalence of dysmenorrhea and its correlating lifestyle factors in japanese female junior high school students. The Tohoku Journal of Experimental Medicine. 2015;2(236):107-113. https://doi.org/10.1620/tjem.236.107
Rigon F, De Sanctis V, Bernasconi S, Bianchin L, Bona G, Bozzola M, Buzi F, Radetti G, Tato L, Tonini G, De Sanctis C, Perissinotto E. Menstrual pattern and menstrual disorders among adolescents: an update of the Italian data. Italian Journal of Pediatrics. 2012;38:38. https://doi.org/10.1186/1824-7288-38-38
Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstetrics and Gynecology. 2006;108(2):428-441. https://doi.org/10.1097/01.aog.0000230214.26638.0c
Harel Z. Dysmenorrhea in adolescents and young adults: an update on pharmacological treatments and management strategies. Expert Opinion on Pharmacotherapy. 2012;13(15):2157-2170. https://doi.org/10.1517/14656566.2012.725045
Henriet P, Gaide Chevronnay HP, Marbaix E. The endocrine and paracrine control of menstruation. Molecular and Cellular Endocrinology. 2012;(2)358:197-207. https://doi.org/10.1016/j.mce.2011.07.042
Latthe PM, Champaneria R, Khan KS. Dysmenorrhoea. BMJ Clinical Evidence. 2011;0813. PMC3275141
Zemtsovskiy EV. Undifferentiated connective tissue dysplasia. The attempt of the new comprehension of the concept. Meditsinskiy vestnik Severnovo Kavkaza. 2008;2:8-15. (In Russ.)
Kadurina TI. Nasledstvennie kollagenopatii. Klinika, diagnostika, lechenie i dispanserizatsiya. SPb: Nevsky dialect; 2000. (In Russ.)
Severin ES. Biochemistry. M.: GEOTAR-Media; 2004;418-421. (In Russ.).
Lesnichenko IF, Gritsaev SV, Kapustin SI. Matrix metalloproteinases: characteristics and role in the leukogenesis and prognostic significance. Voprosi onkologii. 2011;57(3):286-294. (In Russ.)
Ataee M, Zangeneh M, Mahboubi M. Cholecalciferol for primary dysmenorrhea in a college-aged population. Journal of Biology and Today’s World. 2015;4(2):54-57. https://doi.org/10.15412/j.jbtw.01040204
Poulopoulos AK, Andreadis D, Markopoulos AK. Expression of matrix metalloproteinases 9 and 12 in actinic cheilitis. World Journal of Experimental Medicine. 2013;3(3):43-49. https://doi.org/10.5493/wjem.v3.i3.43
Yu XF, Han ZC. Matrix metalloproteinases in bone marrow: roles of gelatinases in physiological hematopoiesis and hematopoietic malignancies. Histopatology. 2006;21:519-531.
Laskowska M. Altered maternal serum matrix metalloproteinases MMP-2, MMP-3, MMP-9, and MMP-13 in severe early- and late-onset preeclampsia. BioMed Research International. 2017; ID 64324261-9. https://doi.org/10.1155/2017/6432426
Rebrov VG, Gromova OA. Vitaminy, makro- i mikroelementy. M.: GEOTAR-Media; 2008. (In Russ.).
Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocrine Reviews. 2005;26(5):662-687. https://doi.org/10.1210/er.2004-0002
Wang Q, He Y, Shen Y, Zhang Q, Chen D, Zuo C, Qin J, Wang H, Wang J, Yu Y. Vitamin D inhibits COX-2 expression and inflammatory response by targeting thioesterase superfamily member 4. The Journal of Biochemical Chemistry. 2014;289(17):11681-11694. https://doi.org/10.1074/jbc.m113.517581
National recommendations of the Russian scientific medical society of therapists on diagnosis, treatment and rehabilitation of patients with connective tissue dysplasia. Meditsinskiy vestnik Severnovo Kavkaza. 2016;11(1):10-11. (In Russ.)
Kuz’menko VV, Fokin VA. Psychological methods of pain quantification. Sovetskaya meditsina. 1986;10:44-48. (In Russ.)
Murawala H, Patel S, Ranadive I, Desai I, Balakrishnan S. Variation in expression and activity pattern of MMP-2 and MMP-9 on different time scales in the regenerating caudal fin of Poecilia latipinna. Journal of Fish Biology. 2018;92(5):1604-1619. https://doi.org/10.1111/jfb.13618
Nigam S, Benedetto C. Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea. Eicosanoids. 1991;4:137-141.

Close metadata